Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth.
Navitoclax（一种 Bcl-2/xL 抑制剂）和 YM155（一种 Survivin 抑制剂）与卡铂联合使用，可有效抑制卵巢癌肿瘤生长
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-23-0863
Kenny Hilary A, Ip Carman Ka Man, Kelliher Lucy, Samantaray Tejas, Kordylewicz Kasjusz, Hoffmann Rachael, Rauch Sarah, Malacrida Beatrice, Skingsley Sophie L P, Balkwill Frances R, Battistini Chiara, Cavallaro Ugo, Wiedemeyer Wolf R, Lengyel Ernst
